BioNTech is a German biotechnology company known for its work in developing and manufacturing innovative therapies, particularly in the field of immunotherapy for cancer treatment and vaccines. It gained significant recognition for its collaboration with Pfizer in producing one of the first COVID-19 vaccines, which utilizes mRNA technology. Founded in 2008, BioNTech focuses on individualized cancer therapies based on messenger RNA (mRNA) and is involved in various stages of research and development, aiming to harness the immune system to target and eliminate cancer cells. The company is also engaged in developing vaccines for infectious diseases.
BioNTech is navigating financial challenges amidst its transition from COVID-19 vaccines to cancer treatments. Earnings dropped significantly, but the company still exceeded market expectations with revenue reaching €1.19 billion. Net…